[Form 4] Intercontinental Exchange Inc. Insider Trading Activity
Rhea-AI Filing Summary
Intercontinental Exchange director Farooqui Duriya M reported a sale of 2,036 shares of ICE common stock on 08/27/2025 at a price of $178.34 per share. The sale was effected pursuant to a Rule 10b5-1 trading plan that was approved and became effective on May 28, 2025. Following the reported transaction, the reporting person beneficially owns an aggregate of 14,299 common stock economic interests, consisting of 12,966 shares of common stock and 1,333 restricted stock units; the restricted stock units vest on the one-year anniversary of the grant date, May 16, 2026. The Form 4 was signed by an attorney-in-fact, Octavia N. Spencer, on 08/29/2025.
Positive
- None.
Negative
- None.
Insights
TL;DR Director sold a modest number of shares under a pre-existing 10b5-1 plan; remaining holdings include vested shares and RSUs vesting in 2026.
The sale of 2,036 shares at $178.34 was completed under a Rule 10b5-1 plan, which limits interpretation as opportunistic insider timing because trades follow an approved plan. The post-transaction beneficial ownership reported is 14,299 economic interests, comprised of 12,966 shares and 1,333 restricted stock units that vest on May 16, 2026. Transaction size is small relative to typical director holdings for a large-cap issuer, and no options or derivative activity were reported. The filing is routine disclosure of an insider sale rather than a corporate event.
TL;DR Director sale executed under a 10b5-1 plan provides procedural compliance and reduces governance concern about opportunistic trading.
The Form 4 explicitly indicates the trade was pursuant to a 10b5-1 plan effective May 28, 2025, which demonstrates use of an affirmative defense for scheduled trades. The disclosure identifies the reporting person as a director and quantifies remaining beneficial ownership, including time-limited restricted stock units vesting May 16, 2026. The signature by an attorney-in-fact is properly provided. From a governance perspective, the filing documents compliance with Section 16 reporting requirements and shows no other material changes in holdings or derivative positions.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 2,036 | $178.34 | $363K |
Footnotes (1)
- This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of May 28, 2025. The common stock number referred in Table 1 is an aggregate number and represents 12,966 shares of common stock and 1,333 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 16, 2026.